mRNA Vaccine for Multiple Sclerosis?
March 9, 2021 | Terry Sharrer
The long-term significance of the COVID-19 vaccines may be greater than stopping the pandemic—great as that is. mRNA technology might be used to arrest the immune reaction of multiple sclerosis and other autoimmune diseases. This piece describes how BioNTech, Pfizer’s partner in developing the COVID-19 vaccine, is looking beyond the pandemic for mRNA technology in healthcare. MORE
Image Credit: Nature.com